Evolent Health Inc
For the period ended Dec 31, 2023. Filed Feb 23, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 23, 2024
EVH$4.71+2.8%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(in thousands, except share data)
| December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $192,825 | $188,200 |
| Restricted cash and restricted investments | 13,768 | 14,492 |
| Accounts receivable, net (1) | 446,749 | 254,684 |
| Prepaid expenses and other current assets | 30,331 | 20,678 |
| Total current assets | 683,673 | 478,054 |
| Restricted cash and restricted investments | 16,864 | 12,466 |
| Investments in equity method investees | 4,895 | 4,475 |
| Property and equipment, net | 78,194 | 87,874 |
| Right-of-use assets - operating | 11,983 | 49,027 |
| Prepaid expenses and other noncurrent assets | 4,028 | 2,378 |
| Contract cost assets | 12,120 | 17,461 |
| Intangible assets, net | 752,009 | 442,784 |
| Goodwill | 1,116,542 | 722,774 |
| Total assets | $2,680,308 | $1,817,293 |
| LIABILITIES, MEZZANINE EQUITY AND SHAREHOLDERS’ EQUITY | ||
| Liabilities | ||
| Current liabilities: | ||
| Accounts payable (1) | $48,246 | $57,174 |
| Accrued liabilities (1) | 149,849 | 111,198 |
| Operating lease liability - current | 9,738 | 7,122 |
| Accrued compensation and employee benefits | 56,385 | 52,460 |
| Deferred revenue | 5,976 | 5,758 |
| Reserve for claims and performance - based arrangements | 404,048 | 199,730 |
| Total current liabilities | 674,242 | 433,442 |
| Long-term debt, net | 597,049 | 412,986 |
| Other long-term liabilities | 3,637 | 4,744 |
| Tax receivables agreement liability | 107,932 | 45,950 |
| Operating lease liabilities - noncurrent | 38,009 | 56,010 |
| Deferred tax liabilities, net | 13,311 | 4,744 |
| Total liabilities | 1,434,180 | 957,876 |
| Commitments and Contingencies (See Note 11) | ||
| Mezzanine Equity | ||
| Preferred class A common stock - $0.01 par value; 50,000,000 shares authorized; 175,000 and 0 shares issued, respectively | 178,427 | — |
| Shareholders' Equity | ||
| Class A common stock - $0.01 par value; 750,000,000 shares authorized; 115,424,833 and 101,500,558 shares issued, respectively | 1,154 | 1,015 |
| Additional paid-in-capital | 1,808,121 | 1,486,857 |
| Accumulated other comprehensive loss | (1,257) | (1,178) |
| Retained earnings (accumulated deficit) | (719,194) | (606,154) |
| Treasury stock, at cost; 1,537,582 shares issued, respectively | (21,123) | (21,123) |
| Total shareholders' equity | 1,067,701 | 859,417 |
| Total liabilities, mezzanine equity and shareholders' equity | $2,680,308 | $1,817,293 |
(1) See Note 20 for amounts attributable to related parties included in these line items.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.